WallStreetZenWallStreetZen

NYSEMKT: SER
Serina Therapeutics Inc Stock Ownership - Who owns Serina Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Serina Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Randall MoreadithChief Scientific Officer2025-12-035,000$3.53
$17.63kSell
Randall MoreadithChief Scientific Officer2025-12-035,000$0.06
$300.00Buy
Randall MoreadithChief Scientific Officer2025-12-021,500$3.91
$5.86kSell
Randall MoreadithChief Scientific Officer2025-12-021,500$0.06
$90.00Buy
Randall MoreadithChief Scientific Officer2025-11-255,965$0.06
$357.90Buy
Randall MoreadithChief Scientific Officer2025-11-255,965$3.90
$23.26kSell
Randall MoreadithChief Scientific Officer2025-11-24535$3.94
$2.11kSell
Randall MoreadithChief Scientific Officer2025-11-24535$0.06
$32.10Buy
Randall MoreadithChief Scientific Officer2025-11-186,500$3.75
$24.40kSell
Randall MoreadithChief Scientific Officer2025-11-186,500$0.06
$390.00Buy

1 of 5

SER insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SER insiders and whales buy or sell their stock.

SER Shareholders

What type of owners hold Serina Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Juvenescence Ltd210.82%22,481,876$73.07MInsider
Juvenescence Us Corp154.23%16,447,500$53.45MInsider
Steven A. Ledger3.04%323,657$1.05MInsider
Vanguard Group Inc1.69%180,013$585.04kInstitution
John F. Mauldin1.17%125,000$406.25kInsider
Broadwood Capital Inc0.78%83,195$270.38kInstitution
Waverly Advisors LLC0.63%67,492$219.35kInstitution
Gregory Bailey0.63%67,243$218.54kInsider
Tacey Viegas0.55%58,610$190.48kInsider
Judith Segall0.49%52,624$171.03kInsider

1 of 3

SER vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SER1.11%98.89%Net BuyingNet Buying
RNXT19.41%11.48%Net BuyingNet Buying
DYAI10.09%89.91%Net Buying
FGEN8.64%91.36%Net BuyingNet Buying
MURA29.83%10.21%Net SellingNet Selling
View Top Biotech Stocks

Serina Therapeutics Stock Ownership FAQ

Who owns Serina Therapeutics?

Serina Therapeutics (NYSEMKT: SER) is owned by 4.16% institutional shareholders, 372.02% Serina Therapeutics insiders, and 0.00% retail investors. Juvenescence Ltd is the largest individual Serina Therapeutics shareholder, owning 22.48M shares representing 210.82% of the company. Juvenescence Ltd's Serina Therapeutics shares are currently valued at $73.07M.

If you're new to stock investing, here's how to buy Serina Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.